Kezdőlap › Multiplex mielóma › Észak-Karolina › Durham
Multiplex mielóma klinikai vizsgálatok: Durham, NC
37 Multiplex mielóma vizsgálat keres résztvevőket Durham és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Toborzás folyamatban3. fázis
- Research Site, Chapel Hill · 10 mérföldre
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban3. fázis
- Duke University Medical Center, Durham
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Toborzás folyamatban2. fázis
- Duke University Medical Center, Durham
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban3. fázis
- Durham VAMC, Durham
- University of North Carolina, Chapel Hill · 10 mérföldre
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Toborzás folyamatban3. fázis
- Durham VAMC, Durham
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Toborzás folyamatban2/3. fázis
- University of North Carolina at Chapel Hill /ID# 277708, Chapel Hill · 10 mérföldre
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Toborzás folyamatban2. fázis
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Toborzás folyamatban3. fázis
- Duke University, Durham
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban2. fázis
- University of North Carolina Medical Center, Chapel Hill · 10 mérföldre
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Toborzás folyamatban1/2. fázis
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · 10 mérföldre
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
Toborzás folyamatban2. fázis
- Duke University Health System, Durham
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mérföldre
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Toborzás folyamatban1/2. fázis
- GSK Investigational Site, Chapel Hill · 10 mérföldre
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- Duke University Hospital, Durham
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Toborzás folyamatban1/2. fázis
- Research Site, Durham
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Toborzás folyamatban3. fázis
- Research Site, Durham
- Research Site, Chapel Hill · 10 mérföldre
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Toborzás folyamatban
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mérföldre
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Toborzás folyamatban1. fázis
- Duke Cancer Center, Durham
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Toborzás folyamatban2. fázis
- UNC Hospitals Adult Oncology Clinics, Chapel Hill · 10 mérföldre
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Toborzás folyamatban1/2. fázis
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · 10 mérföldre
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Toborzás folyamatban1/2. fázis
- Duke Institute of Cancer/ Duke University, Durham
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- University of North Carolina /ID# 251203, Chapel Hill · 10 mérföldre
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Toborzás folyamatban1. fázis
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Toborzás folyamatban2. fázis
- University of North Carolina (Data Collection Only), Chapel Hill · 10 mérföldre
Registry of Older Patients With Cancer
Toborzás folyamatbanMegfigyeléses tanulmány
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mérföldre
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Toborzás folyamatban3. fázis
- Duke University, Durham
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Toborzás folyamatban2. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Toborzás folyamatban2. fázis
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- University of North Carolina Hospitals at Hillsborough, Chapel Hill · 10 mérföldre
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Toborzás folyamatban1/2. fázis
- Duke University Health System (DUHS), Durham
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- University Of North Carolina Health Care - Hillsborough Campus /ID# 278230, Hillsborough · 13 mérföldre
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Toborzás folyamatban1. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Toborzás folyamatban1. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Toborzás folyamatban1/2. fázis
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10 mérföldre
Registry for Adults With Plasma Cell Disorders (PCD's)
Toborzás folyamatbanMegfigyeléses tanulmány
- North Carolina Cancer Hospital, Chapel Hill · 10 mérföldre
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Toborzás folyamatbanMegfigyeléses tanulmány
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mérföldre
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Toborzás folyamatban1. fázis
- Duke University Health System (DUHS), Durham
Multiplex mielóma vizsgálatok más városokban
- New York City, NY60 tanulmány
- Boston, MA42 tanulmány
- Atlanta, GA41 tanulmány
- Houston, TX38 tanulmány
- Nashville, TN32 tanulmány
- Denver, CO27 tanulmány
- Rochester, MN24 tanulmány
- St. Louis, MO24 tanulmány
- Columbus, OH24 tanulmány
- Baldwin Park, CA23 tanulmány
- Chicago, IL22 tanulmány
- Seattle, WA22 tanulmány
Egyéb vizsgálatok: Durham
- Mellrák63 tanulmány
- Rák (minden típus)58 tanulmány
- Nem kis sejtes tüdőrák39 tanulmány
- Áttétes rák33 tanulmány
- Akut mieloid leukémia33 tanulmány
- Tüdőrák32 tanulmány
- Prosztatarák32 tanulmány
- Kolorektális rák28 tanulmány
- Krónikus limfocitás leukémia27 tanulmány
- Petefészekrák27 tanulmány
- Szívelégtelenség26 tanulmány
- Hasnyálmirigyrák24 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 5.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.